Universal-Beteiligungs- und Servicegesellschaft’s Beam Therapeutics BEAM Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.42M	Buy	70,464 +1,451	+2%	+$43.8K	﹤0.01%	1222
2026 Q1	$1.64M	Sell	69,013 -951	-1%	-$26.4K	﹤0.01%	1314
2025 Q4	$1.95M	Sell	69,964 -316	-0.4%	-$8.06K	﹤0.01%	1267
2025 Q3	$1.71M	Buy	70,280 +33,065	+89%	+$658K	﹤0.01%	1358
2025 Q2	$633K	Buy	37,215 +508	+1%	+$8.85K	﹤0.01%	1622
2025 Q1	$717K	Buy	+36,707	New	+$962K	﹤0.01%	1555

Other funds holding BEAM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CGH

Contrarius Group Holdings Hamilton, Bermuda $2.17B AUM 134.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

IEFM

IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's BEAM Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Beam Therapeutics (BEAM) stake by 2.1% in Q2 2026, buying an estimated $43.8K and bringing the position to 70,464 shares worth $2.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in BEAM in Q1 2025 and has held it in 6 quarters since. 161 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Universal-Beteiligungs- und Servicegesellschaft held 70,464 shares of Beam Therapeutics worth $2.42M as of Q2 2026.
Universal-Beteiligungs- und Servicegesellschaft bought 1,451 Beam Therapeutics shares in Q2 2026, an estimated $43.8K.
Beam Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #1222 holding.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Beam Therapeutics in Q1 2025 and has held it in 6 quarters since.
161 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.